Protara Therapeutics, Inc. · NASDAQ:TARA
Citadel Advisors LLC's stake in Protara Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Citadel Advisors LLC's stake in Protara Therapeutics, Inc. fell to 4.70%, 1,627,734 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 1,627,734
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 4.60% | 1,612,531 |
| Citadel Advisors Holdings LP | 4.60% | 1,612,531 |
| Citadel GP LLC | 4.60% | 1,612,531 |
| Citadel Securities LLC | 0% | 15,203 |
| Citadel Securities Group LP | 0% | 15,203 |
| Citadel Securities GP LLC | 0% | 15,203 |
| Kenneth Griffin | 4.70% | 1,627,734 |
Source
Related
- Protara Therapeutics, Inc.
- Citadel Advisors LLC
- Protara Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 7, 2026
- Form 4 · Shefferman Jesse · Jul 1, 2026
- Form 4 · Conkling William · Jun 3, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026